Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase
Autor
Segura-aguilar, J.
Muñoz, Patricia S.
Inzunza, José
Varshney, Mukesh Kumar
Nalvarte, Ivan
Mannervik, Bengt
Resumen
Glutathione is an important antioxidant that plays a crucial role in the cellular protection against oxidative stress and detoxification of electrophilic mutagens, and carcinogens. Glutathione transferases are enzymes catalyzing glutathione-dependent reactions that lead to inactivation and conjugation of toxic compounds, processes followed by subsequent excretion of the detoxified prod-ucts. Degeneration and loss of neuromelanin-containing dopaminergic neurons in the nigrostriatal neurons generally involves oxidative stress, neuroinflammation, alpha-synuclein aggregation to neurotoxic oligomers, mitochondrial dysfunction, protein degradation dysfunction, and endoplas-mic reticulum stress. However, it is still unclear what triggers these neurodegenerative processes. It has been reported that aminochrome may elicit all of these mechanisms and, interestingly, ami-nochrome is formed inside neuromelanin-containing dopaminergic neurons during neuromelanin synthesis. Aminochrome is a neurotoxic ortho-quinone formed in neuromelanin synthesis. How-ever, it seems paradoxical that the neurotoxin aminochrome is generated during neuromelanin syn-thesis, even though healthy seniors have these neurons intact when they die. The explanation of this paradox is the existence of protective tools against aminochrome neurotoxicity composed of the enzymes DT-diaphorase, expressed in these neurons, and glutathione transferase M2-2, expressed in astrocytes. Recently, it has been reported that dopaminergic neurons can be protected by gluta-thione transferase M2-2 from astrocytes, which secrete exosomes containing the protective enzyme.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
DT-Diaphorase Prevents Aminochrome-Induced Lysosome Dysfunction in SH-SY5Y Cells (2020)
Meléndez C.; Muñoz P.; Segura-Aguilar J. (Springer New York LLC, 2019) -
Review
Medicinal plants as protective strategies against parkinson’s disease (2020)
Mazo N.A.; Echeverria V.; Cabezas R.; Ávila-Rodriguez M.; Tarasov V.V.; Yarla N.S.; Aliev G.; Barreto G.E. (Bentham Science Publishers B.V., 2017) -
Article
Timed release of cerebrolysin using drug-loaded titanate nanospheres reduces brain pathology and improves behavioral functions in Parkinson’s disease (2020)
Ozkizilcik A.; Sharma A.; Muresanu D.F.; Lafuente J.V.; Ryan Tian Z.; Patnaik R.; Mössler H.; Sharma H.S. (Humana Press Inc., 2018)